Literature DB >> 34611719

Different number of circulating CD34 + cells in essential thrombocythemia, prefibrotic/early primary myelofibrosis, and overt primary myelofibrosis.

Damien Luque Paz1,2,3, Laurane Cottin1,2,3, Eric Lippert4, Jean-Baptiste Robin5, Charles Bescond5, Franck Genevieve1, Françoise Boyer5, Isabelle Quintin-Roue6, Marie-Christine Rousselet7, Barbara Burroni8, Mathilde Hunault-Berger2,3,5, Valérie Ugo1,2,3, Jean-Christophe Ianotto9, Corentin Orvain10,11,12.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 34611719     DOI: 10.1007/s00277-021-04672-z

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  1 in total

1.  Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders.

Authors:  Francesco Passamonti; Laura Vanelli; Lucia Malabarba; Elisa Rumi; Ester Pungolino; Luca Malcovati; Cristiana Pascutto; Enrica Morra; Mario Lazzarino; Mario Cazzola
Journal:  Haematologica       Date:  2003-10       Impact factor: 9.941

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.